Featured Research

from universities, journals, and other organizations

U Of MN Researchers Find Regular Use Of Aspirin May Lower Risk Of Adult Leukemia

Date:
June 13, 2003
Source:
University Of Minnesota
Summary:
Researchers from the Cancer Center at the University of Minnesota have found that adult women taking aspirin two or more times a week may lower their risk of adult leukemia by more than 50 percent.

MINNEAPOLIS / ST. PAUL -- Researchers from the Cancer Center at the University of Minnesota have found that adult women taking aspirin two or more times a week may lower their risk of adult leukemia by more than 50 percent. The study will be published in the June 13 edition of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

Led by Julie Ross, Ph.D., associate professor of pediatrics and a member of The Cancer Center, researchers analyzed data from the Iowa Women's Health Study to determine whether taking aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen could protect against the leukemia. Since 1985, the Iowa Women's Health Study has followed more than 41,000 post-menopausal women, tracking their overall health, lifestyle, behaviors, and incidence of cancer. For this particular investigation, 28,224 women from that group were included in the study.

"There's a growing body of evidence that aspirin may be a powerful cancer-preventing agent," said Ross. "To our knowledge, this is the first prospective study to examine the association between NSAID use and adult leukemia."

Adult leukemia accounts for nearly 5 percent of all newly diagnosed cancers in the United States. Currently, little is known about what causes leukemia in adults or possible prevention strategies.

Through their research, Ross and her team found that women who developed leukemia took aspirin significantly less often than women who did not develop leukemia. They also found that aspirin appears to have a more potent protective effect for adult leukemia than non-aspirin NSAIDs.

Ross noted that several previous studies in this area have grouped aspirin and non-aspirin NSAIDs together. "A strength of our study was the ability to examine separately the effects of aspirin and non-aspirin NSAIDs," she said. "While the results are preliminary, notable differences in leukemia risk between aspirin and non-aspirin NSAID use definitely call for additional research with other large populations."

Although aspirin is generally a safe drug, it can have adverse effects for some individuals. Before people embark on an aspirin regimen, they should check with their doctor.

Co-authors of this study are Christine Kasum, M.P.H., Cindy Blair, B.S. and Aaron Folsom, M.D., M.P.H.


Story Source:

The above story is based on materials provided by University Of Minnesota. Note: Materials may be edited for content and length.


Cite This Page:

University Of Minnesota. "U Of MN Researchers Find Regular Use Of Aspirin May Lower Risk Of Adult Leukemia." ScienceDaily. ScienceDaily, 13 June 2003. <www.sciencedaily.com/releases/2003/06/030613074256.htm>.
University Of Minnesota. (2003, June 13). U Of MN Researchers Find Regular Use Of Aspirin May Lower Risk Of Adult Leukemia. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2003/06/030613074256.htm
University Of Minnesota. "U Of MN Researchers Find Regular Use Of Aspirin May Lower Risk Of Adult Leukemia." ScienceDaily. www.sciencedaily.com/releases/2003/06/030613074256.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins